Atala Financial’s Biomerica BMRA Stock Holding History

Atala Financial’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-63	Closed	-$284	–	167
2025 Q1	$284	Hold	63	–	–	﹤0.01%	464
2024 Q4	$150	Buy	+63	New	+$166	﹤0.01%	471

Other funds holding BMRA

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Atala Financial's BMRA Position: Q2 2025 in Review

Atala Financial sold out of Biomerica (BMRA) in Q2 2025, closing a stake of 63 shares — an estimated $284 sold.

Atala Financial first reported a position in BMRA in Q4 2024 and held it in 2 quarters. The position peaked at $284 in Q1 2025. 12 funds tracked by Wall St. Rank hold BMRA as of Q2 2025.

Atala Financial reported no remaining Biomerica position as of Q2 2025 after selling out during the quarter.
Atala Financial sold 63 Biomerica shares in Q2 2025, an estimated $284.
Atala Financial first reported a position in Biomerica in Q4 2024 and held it in 2 quarters.
Atala Financial's Biomerica position peaked at $284 in Q1 2025.
12 funds tracked by Wall St. Rank held Biomerica as of Q2 2025.

Based on Atala Financial's 13F filing for Q2 2025, filed 7 Aug 2025.